Yttrium (90Y) tacatuzumab tetraxetan: Difference between revisions
Content deleted Content added
m Robot: sorting stub (based on existing categorisation) |
Tim Q. Wells (talk | contribs) m grammar |
||
| Line 26: | Line 26: | ||
}} |
}} |
||
'''Tacatuzumab tetraxetan''' is a [[Humanize|humanized]] [[monoclonal antibody]] |
'''Tacatuzumab tetraxetan''' is a [[Humanize|humanized]] [[monoclonal antibody]] used to treat cancer. Tacatuzumab has a [[chelator]], [[tetraxetan]]. It has a [[radioisotope]], [[yttrium]]-99Y. |
||
{{monoclonal-antibody-stub}} |
{{monoclonal-antibody-stub}} |
||
Revision as of 19:59, 4 July 2007
Tacatuzumab tetraxetan is a humanized monoclonal antibody used to treat cancer. Tacatuzumab has a chelator, tetraxetan. It has a radioisotope, yttrium-99Y.
 | This monoclonal antibody–related article is a stub. You can help Wikipedia by expanding it. |